Commentary on "Exploring the Phenotypic Profile of Acute Flaccid Paralysis: Insights from a Third-Level Pediatric Emergency Room". [PDF]
Hosseinpour S +4 more
europepmc +1 more source
The global poliovirus eradication initiatives in Kano state, Nigeria: a case report on the African regional commission pre-certification visit and lessons learnt. [PDF]
Nwaze EO, Ieren II, Okafor C.
europepmc +1 more source
Spotlighting Social Compact in Eradication/Elimination Programs. [PDF]
Dasgupta R, Baru RV.
europepmc +1 more source
Acute Transverse Myelitis in a Child Following Oral Live Polio Vaccine Administration. [PDF]
Kramarov S +8 more
europepmc +1 more source
Investigation and response to a type 3 vaccine-derived poliovirus detected in an infant with hand, foot, and mouth disease - Guangdong, China, 2023. [PDF]
Li J +8 more
europepmc +1 more source
Implementation of Poliovirus Containment in Poliovirus Designated Facilities-United States, 2017-2024. [PDF]
Ottendorfer C +8 more
europepmc +1 more source
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial. [PDF]
Hu J +10 more
europepmc +1 more source
An automated assay platform for the evaluation of antiviral compounds against polioviruses. [PDF]
Rhoden EE, Mainou BA.
europepmc +1 more source
Risk Assessments for Type 1 Wild Poliovirus and Type 2 Vaccine-Derived Poliovirus Importation and Transmission - China, 2023. [PDF]
Kang W +15 more
europepmc +1 more source
Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame. [PDF]
Badizadegan K, Thompson KM.
europepmc +1 more source

